MEDIVIR

medivir-logo

Medivir is a research based pharmaceutical company with a research focus on infectious diseases and oncology. Medivir is a protease inhibitor design and the nucleotide/nucleoside science and we are dedicated to developing innovative pharmaceuticals that meet a great unmet medical need. Our commercial organization provides a portfolio of specialty care, pharmaceuticals on the Nordic market.

#SimilarOrganizations #People #Financial #Event #Website #More

MEDIVIR

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
1988-01-01

Address:
Stockholm, Stockholms Lan, Sweden

Country:
Sweden

Website Url:
http://www.medivir.com

Total Employee:
101+

Status:
Active

Contact:
+46 (0)85-468-3100

Email Addresses:
[email protected]

Total Funding:
30.8 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics


Similar Organizations

lonza-logo

Lonza

Lonza Group supplies products and services to pharmaceutical and agrochemical industries.

novo-nordisk-logo

Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.


Current Advisors List

yilmaz-mahshid_image

Yilmaz Mahshid Member Board Of Directors @ Medivir
Board_member
2021-05-01

helena-levander_image

Helena Levander Member of the Board of Directors @ Medivir
Board_member
2015-01-01

Current Employees Featured

jens-lindberg_image

Jens Lindberg
Jens Lindberg CEO @ Medivir
CEO
2021-01-01

not_available_image

Tom Morris
Tom Morris Chief Medical Officer @ Medivir
Chief Medical Officer

magnus-christensen_image

Magnus Christensen
Magnus Christensen CFO @ Medivir
CFO
2021-08-01

Stock Details


Company's stock symbol is STO:MVIR-B

Acquisitions List

Date Company Article Price
2011-04-12 Biophausia AB Biophausia AB acquired by Medivir 62 M EUR

Official Site Inspections

http://www.medivir.com

  • Host name: 104.19.191.28
  • IP address: 104.19.191.28
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Medivir"

About us - Medivir

Medivir is a pharmaceutical company focusing on the development and commercialization of innovative treatments for cancer. Read more. Concept and strategy. Our vision is to improve โ€ฆSee details»

Investors - Medivir

Dec 2, 2024 Medivir AB Box 1086 SE-141 22 Huddinge Visit: Lunastigen 5, 2nd floor. Phone +46 (0)8 5468 31 00 Email [email protected]. Our privacy policy. Read more . Jens Lindberg. โ€ฆSee details»

Medivir - Wikipedia

In 2016 Medivir announced that it would focus its research on cancers of high unmet medical need, where existing therapies are not very successful and there is a great opportunity to provide real benefit to patients who have few treatment options. Some cancer types of particular interest to Medivir include hepatocellular carcinoma (HCC), glioblastoma multiforme (GBM) and pancreatic cancer, which are all highly aggressive diseases with poor treatment options and very low overโ€ฆSee details»

Medivir AB - LinkedIn

Medivir AB | 5,921 followers on LinkedIn. Improving life for cancer patients through transformative drugs | Medivir develops innovative drugs with a focus on cancer where the unmet medical โ€ฆSee details»

Medivir - Crunchbase Company Profile & Funding

Medivir is a research based pharmaceutical company with a research focus on infectious diseases and oncology. Medivir is a protease inhibitor design and the nucleotide/nucleoside โ€ฆSee details»

Om oss - Medivir

Medivir in brief. Medivir is a cutting-edge drug discovery and development company focusing on transformative cancer drugs. Read more. Concept and strategy. Our vision is to improve life โ€ฆSee details»

Medivir AB Company Description - Stock Analysis

Dec 27, 2024 Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and โ€ฆSee details»

Medivir's history

In 2018, Medivir conducted a reorganization to focus on the clinical development of the companyโ€™s projects. 2022 New data on additive efficacy of fostrox in combination with anti-PD1 in โ€ฆSee details»

Medivir - Funding, Financials, Valuation & Investors - Crunchbase

Oct 24, 2020 Medivir is a research-based pharmaceutical company with a research focus on oncology and infectious diseases. Search Crunchbase. Start Free Trial . Chrome Extension. ...See details»

Reports - Medivir

Medivir AB Box 1086 SE-141 22 Huddinge Visit: Lunastigen 5, 2nd floor. Phone +46 (0)8 5468 31 00 Email [email protected]. Our privacy policy. Read more . Jens Lindberg. Chief Executive โ€ฆSee details»

Medivir AB, MVIR:STO profile - FT.com - Financial Times

Dec 10, 2024 Medivir AB is a Sweden-based pharmaceutical research and development company with focus on oncology. The Company specializes in protease inhibitor design and โ€ฆSee details»

Medivir Company Profile - Office Locations, Competitors ... - Craft

Jul 17, 2023 Medivir researches, develops, and sells pharmaceuticals primarily for the treatment of oncology. The Company's products portfolio includes Remetinostat for use in the treatment โ€ฆSee details»

Medivir - Overview, News & Similar companies | ZoomInfo.com

Medivir to present updated clinical data for fostrox + Lenvima in HCC at ESMO Conference in September Stockholm โ€” Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company โ€ฆSee details»

Medivir | European Clinical Trials Information Network

Medivir is a Swedish pharmaceutical company that was founded in 1988. The company has a rich history of developing innovative treatments for infectious diseases and cancer. Over the years, โ€ฆSee details»

Business concept and strategy - medivir.com

In other indications that demand a large marketing organization Medivir intends to seek partners that can secure the fastest route to the market and commercial success. Medivir collaborates โ€ฆSee details»

Medivir Company Profile 2024: Stock Performance & Earnings

Medivir AB develops drugs with a focus on cancers where there are medical needs. The company invests in indication areas where available treatment methods are limited or lacking and there โ€ฆSee details»

Medivir | VentureRadar

Medivir is a pharmaceutical company focusing on the development and commercialization of innovative treatments for cancer. ... Find out more about Medivir including the VentureRadar โ€ฆSee details»

Medivir - Science working wonders

Medivir focuses on cancers of high unmet medical need to provide benefit to patients who so far have had few treatment options. Our projects > Partnering for breadth and depth. Thanks to โ€ฆSee details»

New 'safer supply' clinic is harming Hintonburg, councillor says

1 day ago An Ottawa city councillor says a Hintonburg clinic that prescribes opioids to fentanyl users is harming the community and exacerbating the drug crisis. Northwood Recovery โ€ฆSee details»

News and media

Dec 2, 2024 Medivir AB Box 1086 SE-141 22 Huddinge Visit: Lunastigen 5, 2nd floor. Phone +46 (0)8 5468 31 00 Email [email protected]. Our privacy policy. Read more . Jens Lindberg. โ€ฆSee details»

linkstock.net © 2022. All rights reserved